Building Philanthropy for a Better Florida

'Double Decker' Antibody Technology Fights Cancer

October 25, 2017

Scientists from the Florida campus of The Scripps Research Institute (TSRI) have created a new class of antibody-drug conjugates (ADCs), using a versatile “double decker” technology that ties antibodies and a drug together to produce highly potent pharmaceuticals for cancer therapy.

Find More By

News type
Funding Area